Interaction between renin-angiotensin system and cholinergic system in brain

Area of Science:

• Neuroscience
• Pharmacology
• Cardiovascular Physiology

Background:

• Angiotensin II (ANG II) plays a crucial role in regulating blood pressure and fluid balance.
• The involvement of central cholinergic pathways in mediating ANG II's effects is not fully understood.

Purpose of the Study:

• To investigate the role of central acetylcholine in mediating the cardiovascular and behavioral effects of intraventricularly administered Angiotensin II in rats.

Main Methods:

• Rats received intracerebroventricular (i.c.v.) injections of hemicholinium-3 (HC-3) to deplete acetylcholine.
• Cholinergic antagonists (atropine, mecamylamine) and agonists (physostigmine, carbachol) were administered.
• Cardiovascular parameters (mean arterial pressure, heart rate) and drinking behavior were monitored.
• Effects of renin-angiotensin system inhibitors (saralasin, captopril) were assessed.

Main Results:

• Hemicholinium-3 reduced ANG II-induced increases in mean arterial pressure and drinking, but not heart rate changes.
• Atropine and mecamylamine partially blocked ANG II's pressor response, with higher atropine doses affecting bradycardia.
• Intravenous atropine, but not its methylbromide analog, reduced ANG II-induced drinking.

Conclusions:

• Central acetylcholine, acting via muscarinic receptors, partially mediates Angiotensin II-induced hypertension and thirst.
• The bradycardia induced by Angiotensin II is not mediated by the baroreceptor reflex.
• The brain renin-angiotensin system does not influence cholinergic stimulation's cardiovascular and behavioral effects.